KLOW 80MG

KLOW is a lyophilized multi-peptide research blend containing TB-500 (10mg), BPC-157 (10mg), GHK-Cu (50mg), and KPV (10mg). This formulation combines four peptides with complementary research profiles: TB-500, a thymosin beta-4 fragment studied for its role in cell migration and extracellular matrix remodeling; BPC-157, a gastric pentadecapeptide investigated for cytoprotective and angiogenic properties; GHK-Cu, a copper-binding tripeptide studied for gene expression modulation and tissue remodeling; and KPV, an alpha-MSH-derived tripeptide researched for its anti-inflammatory and antimicrobial signaling effects. Published research on each component peptide supports their relevance in regenerative biology and inflammatory pathway studies. This 80mg lyophilized blend is intended strictly for in vitro research and laboratory investigation. Not for human consumption.